Our study suggests that the circZNF91/miR-1283/WEE1 axis may be engaged in the progression of CLL and understanding the dysregulation of circZNF91 could provide insights into novel therapy development of CLL. Here, WEE1 is linked to B-cell chronic lymphocytic leukemia.